Lactobacillus improves H. pylori treatmentEfficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis.
We examined the impact of Lactobacillus spp. on diarrhea related to Helicobacter pylori infections through a comprehensive analysis of 26 studies. Our findings suggest that using Lactobacillus significantly improves H. pylori eradication rates and reduces gastrointestinal side effects, including diarrhea.
Supplementation was particularly effective when paired with standard triple therapy, showing promising results, especially in children. This positions Lactobacillus as a valuable adjunct treatment option for managing these infections while reducing discomfort.
Read More
Probiotics reinforce intestinal barriersA Probiotic Mixture of LR 32, BL 04, and BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1.
We explored the potential of a multi-strain probiotic blend (Serobioma) in improving gut health for individuals with Irritable Bowel Syndrome (IBS).
Using samples from 28 IBS patients and 7 healthy controls, we examined how this probiotic affects the intestinal barrier.
The results were promising: Serobioma significantly strengthened the intestinal lining and countered permeability changes caused by IBS-related substances. This was especially true for IBS patients who primarily experienced diarrhea, suggesting that probiotics could be a useful addition to their treatment plans.
Read More
Turcz. mitigates antibiotic-induced diarrhea[ Turcz. alleviates antibiotic-associated diarrhea in mice by modulating gut microbiota structure and regulating the EGFR/PI3K/Akt signaling pathway].
We explored how Turcz. (TCT) can alleviate antibiotic-associated diarrhea (AAD) in a mouse model. Through various research methods, we observed that TCT significantly improved gut health by enhancing microbiota diversity and regulating specific signaling pathways.
Treatment with TCT led to less inflammation, indicated by lower levels of IL-6 and TNF-α, and improved colon tissue structure. Notably, TCT increased beneficial bacteria like Lactobacillus. This study highlights a promising approach to managing AAD through natural compounds.
Read More
Lactobacillus reduces diarrhea in childrenLactobacillus reuteri protectis DSM 17938 at high doses versus placebo in children with acute gastroenteritis in a Pediatric Emergency Department.
We evaluated the effectiveness of Lactobacillus reuteri DSM 17938 as an addition to oral rehydration therapy for children suffering from acute gastroenteritis. This randomized, controlled trial took place in a pediatric emergency setting and included children aged 1 month to 5 years.
The results indicated that those treated with Lactobacillus experienced a notable reduction in the duration and frequency of diarrhea compared to those given a placebo. With a safe profile at high doses, this probiotic shows promise as a simple, low-risk solution to alleviate diarrhea in young patients.
Read More
Effective probiotic for poultry diarrheaLeveraging Lactobacillus plantarum probiotics to mitigate diarrhea and Salmonella infections in broiler chickens.
We explored the impact of Lactobacillus plantarum (LP) probiotics on reducing diarrhea caused by Salmonella in broiler chickens. Our study used different growth media for LP, revealing that the MRS medium yielded a probiotic formulation that significantly boosted body weight and reduced diarrhea by up to 86.45%.
This impressive outcome suggests that LP not only strengthens gut health but also helps combat harmful bacteria. Our findings indicate that LP could be a safe and eco-friendly option for improving poultry health and productivity.
Read More